Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-03-03

FDA Approved: BENZONATATE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Benzonatate by Zydus Pharmaceuticals USA Inc., authorizing changes under the ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benzonatate (BENZONATATE)

Snippet

SUPPL AP for BENZONATATE (BENZONATATE)